Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup

Publikation: Bidrag til tidsskriftReviewForskningpeer review

  1. European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancer

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Randomized trial of cytoreductive surgery for relapsed ovarian cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research
Vis graf over relationer

The Gynecologic Cancer InterGroup (GCIG) sixth Ovarian Cancer Conference on Clinical Research was held virtually in October, 2021, following published consensus guidelines. The goal of the consensus meeting was to achieve harmonisation on the design elements of upcoming trials in ovarian cancer, to select important questions for future study, and to identify unmet needs. All 33 GCIG member groups participated in the development, refinement, and adoption of 20 statements within four topic groups on clinical research in ovarian cancer including first line treatment, recurrent disease, disease subgroups, and future trials. Unanimous consensus was obtained for 14 of 20 statements, with greater than 90% concordance in the remaining six statements. The high acceptance rate following active deliberation among the GCIG groups confirmed that a consensus process could be applied in a virtual setting. Together with detailed categorisation of unmet needs, these consensus statements will promote the harmonisation of international clinical research in ovarian cancer.

OriginalsprogEngelsk
TidsskriftThe Lancet Oncology
Vol/bind23
Udgave nummer8
Sider (fra-til)e374-e384
ISSN1470-2045
DOI
StatusUdgivet - aug. 2022

Bibliografisk note

Copyright © 2022 Elsevier Ltd. All rights reserved.

ID: 79999973